Elevance alleges that CMS unlawfully refused to recalculate its 2026 Medicare Advantage Star Ratings on the same basis that it recently recalculated Clover Health's ratings after a court ruling.
A new report finds private equity firms are increasingly using joint ventures with nonprofit health systems to expand in healthcare, prompting calls for greater oversight.
LexisNexis sat down with John Ursin, Managing Partner at Schenck Price, to learn how the firm is using legal AI to strengthen client service and daily legal work.
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program
A 'cynical optimist' breaks down how law impacts the healthcare you receive.
The Medicare Cost Cap Act seeks to create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries.
The biotech IPOs window is now open, but that doesn’t mean every company can go through it.
Grounded in authoritative content and verified at every step, Protégé is the only legal AI tool that delivers work you can trust—without exception.
Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed.
KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025.
This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging back to regulatory flexibility.
FDA concerns about Amgen’s Tavneos were sparked by securities fraud litigation against ChemoCentryx, the company that originally developed the rare disease drug. The FDA wants to withdraw Tavneos’s approval, citing safety risks and alleged manipulation of the drug’s clinical trial data.
Once you’ve got your law degree, how do you keep your professional skills up to date? Share your perspective in this brief survey, and you may be eligible to win a $250 gift card.
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs.
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines.
Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency.
The Massachusetts attorney general sued UnitedHealthcare, alleging the insurer improperly inflated MassHealth members’ health risk scores to secure at least $100 million in excess payments.
Abridge, Highmark Health, and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health, and Novartis.